Ganesh Samala

Ganesh Samala

Auto-generated profile, based on publicly available information

Ganesh Samala

Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Shameerpet, Hyderabad 500078, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GSGanesh Samala
Ganesh Samala
PDParthiban Brindha Devi
Parthiban Brindha Devi
SSShalini Saxena
Shalini Saxena
NMNikhila Meda
Nikhila Meda
PYPerumal Yogeeswari
Perumal Yogeeswari
DSDharmarajan Sriram
Dharmarajan Sriram

1 October 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
SZSanyong Zhu
Sanyong Zhu
GSGanesh Samala
Ganesh Samala
ESEric T. Sletten
Eric T. Sletten
JSJennifer L Stockdill
Jennifer L Stockdill
HNHien M. Nguyen
Hien M. Nguyen
Studies of S-linked glycoconjugates have attracted growing interest because of their enhanced chemical stability and enzymatic resistance over O-glycoside counterparts. We here report a facile approach to access α-1,2-cis-S-linked glycosides using triflic acid as a catalyst to promote the glycosylation of a series of thiols with D-glucosamine, galactosamine, glucose, and galactose electrophiles. This method is broadly applicable for the stereoselective synthesis of S-linked glycopeptides, oligosaccharides and glycolipids in high yield and excellent α-selectivity. Many of the synthetic limitations associated with the preparation of these S-linked products are overcome by this catalytic method.

21 October 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
Vijay SoniVijay Soni
Vijay Soni
SUSandeep Upadhayay
Sandeep Upadhayay
PSPriyanka Suryadevara
Priyanka Suryadevara
GSGanesh Samla
Ganesh Samla
ASArchana Singh
Archana Singh
VNVinay Kumar Nandicoori
Vinay Kumar Nandicoori
M. tuberculosis N-acetyl-glucosamine-1-phosphate uridyltransferase (GlmUMtb) is a bi-functional enzyme engaged in the synthesis of two metabolic intermediates N-acetylglucosamine-1-phosphate (GlcNAc-1-P) and UDP-GlcNAc, catalyzed by the C- and N-terminal domains respectively. UDP-GlcNAc is a key metabolite essential for the synthesis of peptidoglycan, disaccharide linker, arabinogalactan and mycothiols. While glmUMtb was predicted to be an essential gene, till date the role of GlmUMtb in modulating the in vitro growth of Mtb or its role in survival of pathogen ex vivo / in vivo have not been deciphered. Here we present the results of a comprehensive study dissecting the role of GlmUMtb in arbitrating the survival of the pathogen both in vitro and in vivo. We find that absence of GlmUMtb leads to extensive perturbation of bacterial morphology and substantial reduction in cell wall thickness under normoxic as well as hypoxic conditions. Complementation studies show that the acetyl- and uridyl- transferase activities of GlmUMtb are independently essential for bacterial survival in vitro, and GlmUMtb is also found to be essential for mycobacterial survival in THP-1 cells as well as in guinea pigs. Depletion of GlmUMtb from infected murine lungs, four weeks post infection, led to significant reduction in the bacillary load. The administration of Oxa33, a novel oxazolidine derivative that specifically inhibits GlmUMtb, to infected mice resulted in significant decrease in the bacillary load. Thus our study establishes GlmUMtb as a strong candidate for intervention measures against established tuberculosis infections. The synthesis of the Mtb cell wall involves a cascade of reactions catalyzed by cytosolic and cell membrane-bound enzymes. The reaction catalyzed by GlmUMtb (an enzyme with acetyltransferase and uridyltransferase activities) generates UDP-GlcNAc, a central nucleotide-sugar building block of the cell wall. Apart from cell wall synthesis UDP-GlcNAc is an essential metabolite participating in other cellular processes including disaccharide linker and mycothiol biosynthesis. GlmUMtb shares very little sequence similarity with eukaryotic acetyltransferase and uridyltransferase enzymes. Many pathogens have alternative pathway(s) for foraging GlcNAc from the host. The present study was undertaken to see the effects of depleting GlmUMtb on pathogen survival in the host animal. We have generated a conditional gene replacement mutant of glmUMtb and find that depletion of GlmUMtb at any stage of bacterial growth or in mice infected with Mtb including a well-established infection, results in irreversible bacterial death due to perturbation of cell wall synthesis. We have developed a novel anti-GlmUMtb inhibitor (Oxa33), identified its binding site on GlmUMtb, and shown its specificity for GlmUMtb. The study demonstrates that GlmUMtb is a promising target for therapeutic intervention and Oxa33 can be pursued as a lead molecule.

1 March 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSShalini Saxena
Shalini Saxena
GSGanesh Samala
Ganesh Samala
JSJonnalagadda Padma Sridevi
Jonnalagadda Padma Sridevi
PDParthiban Brindha Devi
Parthiban Brindha Devi
PYPerumal Yogeeswari
Perumal Yogeeswari
DSDharmarajan Sriram
Dharmarajan Sriram

12 September 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GSGanesh Samala
Ganesh Samala
PDParthiban Brindha Devi
Parthiban Brindha Devi
RNRadhika Nallangi
Radhika Nallangi
PYPerumal Yogeeswari
Perumal Yogeeswari
DSDharmarajan Sriram
Dharmarajan Sriram

1 March 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GSGanesh Samala
Ganesh Samala
PDParthiban Brindha Devi
Parthiban Brindha Devi
RNRadhika Nallangi
Radhika Nallangi
JSJonnalagadda Padma Sridevi
Jonnalagadda Padma Sridevi
SSShalini Saxena
Shalini Saxena
DSDharmarajan Sriram
Dharmarajan Sriram